**Question:** Michaelis Gutmann bodies are seen in -

A. Alzheimer's disease
B. Creutzfeldt-Jakob disease
C. Parkinson's disease
D. Huntington's disease

**Core Concept:** Michaelis Gutmann bodies are neuropathological features observed in certain neurodegenerative disorders. They are protein aggregates composed of hyperphosphorylated tau and hyperphosphorylated α-synuclein proteins. This phenomenon signifies the process of neurodegeneration and is associated with specific neurodegenerative diseases.

**Why the Correct Answer is Right:** Michaelis Gutmann bodies are identified in neurodegenerative diseases characterized by the accumulation of abnormal proteins. In this case, the correct answer (D) is related to Huntington's disease, which is an autosomal dominant neurodegenerative disorder caused by an expanded CAG trinucleotide repeat in the HTT gene. The presence of these bodies indicates protein aggregation, a hallmark of neurodegeneration, and the specific disease process involved in Huntington's disease.

**Why Each Wrong Option is Incorrect:**

A. Alzheimer's disease is related to amyloid plaques and neurofibrillary tangles, not Michaelis Gutmann bodies. Alzheimer's disease is primarily associated with extracellular amyloid-beta plaques and intracellular neurofibrillary tangles, which are distinct pathological features.

B. Creutzfeldt-Jakob disease is a prion disease characterized by the accumulation of misfolded proteins (PrPSc) leading to neuronal dysfunction and death. Creutzfeldt-Jakob disease is not directly related to Michaelis Gutmann bodies.

C. Parkinson's disease is characterized by the accumulation of Lewy bodies, which consist of α-synuclein protein aggregates, rather than Michaelis Gutmann bodies.

**Clinical Pearl:** Understanding Michaelis Gutmann bodies can aid in differentiating between various neurodegenerative diseases based on the specific pathological features observed. This knowledge is crucial for accurate diagnosis and appropriate therapeutic approaches in clinical practice.